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The terminal 22q13.3 deletion syndrome is characterized by severe expressive-language delay, mild mental retar-
dation, hypotonia, joint laxity, dolichocephaly, and minor facial dysmorphisms. We identified a child with all the
features of 22q13.3 deletion syndrome. The patient’s karyotype showed a de novo balanced translocation between
chromosomes 12 and 22, with the breakpoint in the 22q13.3 critical region of the 22q distal deletion syndrome
[46, XY, t(12;22)(q24.1;q13.3)]. FISH investigations revealed that the translocation was reciprocal, with the chro-
mosome 22 breakpoint within the 22q subtelomeric cosmid 106G1220 and the chromosome 12q breakpoint near
STS D12S317. Using Southern blot analysis and inverse PCR, we located the chromosome 12 breakpoint in an
intron of the FLJ10659 gene and located the chromosome 22 breakpoint within exon 21 of the human homologue
of the ProSAP2 gene. Short homologous sequences (5-bp, CTG[C/A]C) were found at the breakpoint on both
derivative chromosomes. The translocation does not lead to the loss of any portion of DNA. Northern blot analysis
of human tissues, using the rat ProSAP2 cDNA, showed that full-length transcripts were found only in the cerebral
cortex and the cerebellum. The FLJ10659 gene is expressed in various tissues and does not show tissue-specific
isoforms. The finding that ProSAP2 is included in the critical region of the 22q deletion syndrome and that our
proband displays all signs and symptoms of the syndrome suggests that ProSAP2 haploinsufficiency is the cause
of the 22q13.3 deletion syndrome. ProSAP2 is a good candidate for this syndrome, because it is preferentially
expressed in the cerebral cortex and the cerebellum and encodes a scaffold protein involved in the postsynaptic
density of excitatory synapses.
Introduction
Recent approaches to the analysis of chromosome ter-
minal regions led to the detection of several patients
who had chromosome 22q distal deletions (Nesslinger
et al. 1994; Flint et al. 1995; Precht et al. 1998; Prasad
et al. 2000). The terminal 22q13.3 deletion syndrome
is characterized by severe expressive-language delay
and mild mental retardation; minor dysmorphisms
have been reported in some subjects (Wong et al.
1997; Precht et al. 1998; Prasad et al. 2000). On the
basis of clinical and molecular studies of patients with
either macroscopic or submicroscopic cytogenetic re-
arrangements, Wong and colleagues (1997) narrowed
(to 70 kb) the shortest region of deletion overlap
(SRO) in which the gene(s) involved in 22q13.3 de-
letion syndrome should be localized.
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We describe a child who has a de novo balanced trans-
location between chromosomes 12 and 22, with the
breakpoint in the 22q13.3 critical region. The child has
all the features of terminal deletion 22q syndrome. Mo-
lecular investigations have demonstrated that the trans-
location disrupts the human homologue of the proline-
rich synapse-associated protein 2 (ProSAP2) (Boeckers
et al. 1999a) gene on chromosome 22 and the FLJ10659
gene on chromosome 12. Two facts make ProSAP2 a
good candidate for the 22q13.3 deletion syndrome: (1)
it is expressed preferentially in the cerebral cortex and
the cerebellum, and (2) it encodes a scaffold protein
involved in the postsynaptic density (PSD) of excitatory
synapses. Recent breakthroughs have, in fact, shown
that mutations of genes regulating synaptic vesicle trans-
port result in mental retardation (Chelly 2000; Toniolo
and D’Adamo 2000).
Subject and Methods
Subject
The proband is a 4.5-year-old boy. Family history is
negative for mental retardation and other neurological
or psychiatric disorders. Pregnancy, delivery, and neo-
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natal life were unremarkable. Early motor milestones
were slightly delayed—the infant sat at age 7 mo and
walked at age 19 mo. However, language development
was severely compromised, in that the boy was unable
to utter single words until he was 2 years old. At age
4.5 years (last evaluation), his verbal expression was
limited to a few words; he had mild mental retardation
(overall IQ 54) and sharply limited verbal abilities (ver-
bal IQ 32; performance IQ 70). Neurological exami-
nation revealed mild hypotonia and minor dysmorphic
features (dolichocephaly, epicanthic folds, and saddle
nose with bulbous tip) are evident. Results of audio-
metric testing, needle electromyography, and cranial
magnetic resonance imaging are normal.
Cytogenetic Investigations
Chromosome analysis was performed on the pro-
band’s and parents’ blood, using standard high-resolu-
tion techniques (Dutrillaux 1981). Whole-chromosome
painting (with a chromosome 22–specific library [Cy-
tocell]) and FISH (with 22q subtelomere–specific cosmid
106G1220 [Vysis]), were performed on the proband’s
metaphase spreads. Other FISH experiments were per-
formed with YACs that were selected according to their
position on the Genome Database. YAC DNA was la-
beled with biotin, by nick translation. The labeled probes
were visualized with fluorescein isothiocyanate–avidin
(Vector), and the chromosomes were counterstained
with 4′,6-diamino-2-phenyl-indole (Sigma). Hybridiza-
tions were analyzed with a Zeiss Axioplan epifluoresc-
ence microscope, and images were captured with the
Power Gene FISH System (PSI).
DNA Analysis
For Southern blot analysis, 20-mg aliquots of genomic
DNA from the proband and his parents were digested
using EcoRI, EcoRV, and HindIII and were separated
by size on a 0.7% agarose/0.5# TBE gel. The DNAwas
then transferred to a nylon membrane (Boehringer
Mannheim).
Two micrograms of DNA from clone n85a3 (Genome
Database accession number AC000036) was cut with
EcoRV, isolated on a 0.4% agarose/1# TAE gel, and
purified with Qiaex II (Qiagen). Approximately 200 ng
of each fragment was labeled with [32P] dCTP by random
priming. Labeled probes were preannealed with COT-1
DNA (Gibco) for 30 min at 65C, then hybridized over-
night at 65C in Church’s buffer (Church and Gilbert
1984), washed, and photographed using KodakX-Omat
AR film.
Inverse PCR was performed on MscI-digested ligated
(in 1-ml volumes to facilitate self-ligation of individual
fragments) genomic DNA, using nested sets of primers
at different positions. Amplified fragments were isolated
on a 1% agarose/Tris-acetate-EDTA gel, purified with
Qiaex II, and sequenced with a Big Dye terminator cycle
sequencing kit (Applied Biosystems). Sequence analysis
was performed on an ABI Prism 310 genetic analyzer.
All primer sequences and amplification protocols are
available, on request, from the authors.
Northern analysis was performed on human multiple-
tissue northern blots (Clontech Laboratories), according
to the manufacturer’s protocols. [32P]-labeled rat
ProSAP2 cDNA (Boeckers et al. 1999a) and FLJ10659
cDNA (IMAGE: 3450646) were used as probes.
Results
Cytogenetic and Molecular Studies
Standard cytogenetic investigations in the proband
showed a chromosome translocation: 46, XY, t(12;22)
(q24.1;q13.3) (fig. 1). No 22q bands were visible on
der(12). The translocation’s reciprocity was demon-
strated by FISH, using the 22q subtelomere–specific
cosmid 106G1220 (Ning et al. 1996). No signals were
seen on der(12) after FISH with a chromosome 22
painting library, whereas two signals, one on der(12)
and one on der(22), were visible after FISH with
106G1220 (fig. 1). Thus, the translocation appeared
to be reciprocal, with the chromosome 22 breakpoint
within probe 106G1220. Fine localization of the
breakpoint on chromosome 12q was performed using
YAC clones localized in 12q24 (contig WC-841). Sig-
nals from the overlapping YACs (948-E-9 and 901-
A-5) were found on both derivative chromosomes,
whereas YAC 764-F-2 gave a signal only on der(12).
Thus, the breakpoint on chromosome 12q lies near
STS D12S317 (115 cM from the 12p telomere).
After Southern blot hybridization with fragments cor-
responding to bases 22039–41000 (fragment A), 4238–
15981 (fragment B), and 15981–22039 (fragment C)
from cosmid n85a3 (fig. 2), several bands (fig. 2) showed
a decrease in relative signal strength in the proband,
whereas additional bands (fig. 2) appeared. The break-
point’s location could be narrowed to the region shared
by the fragments with reduced signal, from the EcoRV
site at position 295109 to the HindIII site at position
299969 (all nucleotide positions refer to the chromo-
some 22 sequence, locus NT_024379 [Dunham et al.
1999]).
The breakpoint was cloned by inverse PCR and was
confirmed by specific amplification of both der(12) and
der(22) breakpoints (fig. 3). Sequencing of the break-
points showed that the chromosome 12 sequence is ex-
actly split between the derivative chromosomes, whereas
5 bases around the chromosome 22 breakpoint are pre-
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Figure 1 A (top), Cut-out of normal chromosomes 12 and 22,
aligned with their homologue translocation derivatives der(12) and
der(22) in G-banding at a resolution of 550 bands. A (bottom),
Corresponding high-resolution G-banding ideograms of chromosomes
12 (green) and 22 (red) and their derivatives der(12) (green with a
small red portion) and der(22) (red with a green portion). Arrowheads
indicate the breakpoints in subbands 12q24.1 and 22q13.3. The re-
ciprocal exchange of chromosome material involves a larger region
from chromosome 12 than from chromosome 22 (see ideogram); no
22q material is visible on der(12), when examined by cytogenetics or
FISH with a 22-painting library. B, Results of FISH with the 22q
subtelomeric probe 106G1220 (VYSIS). The normal chromosome 22
(arrow) and both der(12) and der(22) (arrowheads) show a signal
demonstrating the translocation’s reciprocity, with the chromosome
22 breakpoint within probe 106G1220.
sent on both derivative chromosomes (fig. 3). The chro-
mosome 22 breakpoint lies at position 296489/296494,
within exon 21 of the human homologue of rat ProSAP-
2 (Boeckers et al. 1999a), Shank-3 (Lim et al. 1999),
and SPANK-2 (Naisbitt et al. 1999). The chromosome
12 breakpoint is localized at ∼5 kb from the D12S317
locus (contig NT_024379), between exons 10 and 11 of
the gene for the hypothetical protein FLJ10659
(XM_006601) (fig. 3).
Structure of the Human ProSAP2 and FLJ10659 Genes
The structure of the human ProSAP2 gene was de-
duced by comparing the chromosome 22 sequence
(NT_001128) with the rat ProSAP2 cDNA
(NP_067707), using BLAST2. The structure of the
FLJ10659 gene was already known and can be browsed
using LocusLink. The ProSAP2 gene spans a 60-kb re-
gion on chromosome 22, between arylsulfatase A
(ARSA) and acrosin, and is coded by 22 exons (fig. 2).
An additional 27-bp exon (exon 21b) was found by com-
paring the human sequence to rat Shank-3A cDNA
(NP_067708); however, it may not be functional, be-
cause it does not appear to have a correct 3′-splice se-
quence. In fact, PCR analysis shows that exon 21b is
not present in the ProSAP2 transcript from human brain
tissue (fig. 3).
Exon 1 contains the ATG start codon, if we assume
that the human ProSAP2 translation start codon is the
same as that in rat and mouse cDNAs. Exon 22 contains
the stop codon and, presumably, the whole 3′ nontrans-
lated portion of the cDNA. This portion has not been
sequenced in rats or mice. BLAST analysis of the human
genomic sequence against human expressed-sequence
tags (data not shown) suggests that AATAAA motifs at
positions 308209 and 308619 are the most-frequently
used polyadenylation signals. Nucleotide-sequence iden-
tity is 86% overall and is conserved throughout the gene
(data not shown). The gene codes for a 1731aa protein.
Intron-exon boundaries, except for exon 21b, conform
to the canonical sequence (data not shown).
The FLJ10659 gene spans a 63-kb region of chro-
mosome 12 and is composed of 21 exons (fig. 2). The
ATG start codon is located on exon 1, and the stop
codon is located on exon 18. The gene codes for a 541aa
protein.
Expression Pattern of Human ProSAP2 and FLJ10659
Northern blot analysis of human tissues, using a full-
length rat ProSAP2 cDNA probe, has shown multiple
transcripts (fig. 3). A 3-kb band is expressed at varying
levels in different tissues, more strongly in heart, kidney,
liver, and placenta. Two longer transcripts (7 and 8 kb)
are seen exclusively in brain tissue.
Analysis of different CNS regions shows ubiquitous
expression of the 3-kb band; however, a 7-kb band is
not present in the medulla or spinal cord, and an 8-kb
band is specific to cortical samples. We have repeated
the hybridization, using two probes from different por-
tions of the human ProSAP2 cDNA: a 400-bp fragment
containing exon 11 and a portion of exons 10 and 12
(including a 150-bp fragment that codes for the SH3
domain) and a 1.7-kb portion of exon 21 that has no
known similarity to other genes. The exon 21 probe only
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Figure 3 A, Expression of ProSAP2 and FLJ10659. Commercial northern blot analysis was performed using 2 mg per lane of poly-A
RNA from human tissues (panels a and c), and human brain tissues (panels b and d). The filters were hybridized to rat ProSAP2 cDNA (panels
a and b) or IMAGE clone 3450646 (panels c and d). Filters a and b were exposed for 2 w, and filters c and d were exposed for 40 h. B, PCR
analysis of human ProSAP2 expression. Groups of exons spanning most of the gene’s coding region (exons 1/4, 10/12, 10/16, 16/21, and 21/
22) were amplified from human brain (b), cerebellum (c), and heart (h) cDNAs using a nested PCR protocol. Negative control amplifications
() were always included. Human b-actin cDNA was used as a control, and amplified at similar levels in all tissues. Some products (exons 1/
4, 10/12, and 21/22) were visible after the primary amplification (PCR 1), but others (exons 10/16 and 16/21) required a secondary amplification
(PCR 2). All amplified fragments were isolated and sequenced. The smallest fragment (200 bp) from the secondary amplification of exons 10/
12 from brain tissue does not contain exon 11. The 540-bp fragment from the secondary amplification of exon 10/16 from brain tissue does
not contain exons 11 and 12, but the 600-bp fragment from heart in the same panel was amplified from genomic DNA. The 128-bp fragment
from the primary amplification of exons 21/22 from brain tissue does not contain exon 21b. All other fragments have the expected sequence.
hybridizes to the longer bands (7, 8, and 12–15 kb),
whereas the exon 10-12 probe hybridizes to the longer
bands in brain and to additional smaller bands (2–2.3
kb) in several tissues (data not shown). Neither probe
hybridizes to the 3-kb band seen with the rat probe.
To determine whether the smaller bands represent dif-
ferentially spliced ProSAP2 transcripts or are the result
of cross-hybridization with other members of the
ProSAP family or other PDZ/SH3 domain-containing
transcripts, we have amplified fragments spanning most
of the coding region of the gene from human cortex,
cerebellum, and heart cDNAs (fig. 3). ProSAP2 was al-
ways amplified in tissue from the cerebral cortex; how-
ever, the cerebellum gave somewhat mixed results, and
results were always negative in heart tissue.
These results strongly suggest that human ProSAP2 is
expressed primarily in the brain, at least in adults, and
that the sizes of its transcripts are 7 and 8 kb. The size
difference between the larger bands probably results
from different polyadenylation sites. The 12–15-kb band
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that is visible mainly in the cerebellum may represent an
incompletely spliced transcript. Differential splicing
events, which have been extensively described in rats
(Lim et al. 1999), can also occur in human ProSAP2 (fig.
3). The smaller bands detected in many tissues with the
rat cDNA and the exon 10–12 probe are almost certainly
cross-hybridizations with other transcripts containing
PDZ, SH3, or SAM domains.
The FLJ10659 probe hybridizes to a 4-kb transcript
expressed in several tissues, including kidney, brain,
heart, and skeletal muscle. The transcipt is expressed in
all CNS samples (fig. 3).
Discussion
The introduction of new methods aimed at checking the
telomere’s integrity is leading to the definition of new
malformation syndromes (Knight and Flint 2000; De
Vries et al. 2001). Among those recently defined is the
22q distal deletion syndrome. Flint and colleagues
(1995) detected the first cryptic 22q deletion while
screening for the abnormal inheritance of subtelomeric
DNA polymorphisms in subjects with mental retarda-
tion. Since then, several instances of 22q distal deletion,
not detectable by conventional cytogenetic techniques,
have been found. Some were detected while screening
for cryptic subtelomeric rearrangements in patients with
mental retardation (Knight and Flint 1999). Others
(with a generic “chromosomal phenotype”) were de-
tected during exclusion of a deletion at the diGeorge/
velocardiofacial region (Goizet et al. 2000; Praphanphoj
et al. 2000; Prasad et al. 2000). In fact, commercially
available diGeorge probes include 22q distal probes as
a control. Although most subjects who have cryptic telo-
meric rearrangements are affected by mental retardation
associated with congenital anomalies and facial dys-
morphisms (Knight and Flint 2000), most subjects who
have 22q distal deletions are ascertained because of mild
mental retardation and delayed speech (Flint et al. 1995;
Precht et al. 1998). In these subjects, expressive language
is either absent or severely delayed. Less frequently de-
scribed traits include epicanthic folds, bulbous nose, dys-
plastic ears, dolichocephaly, hypotonia, joint laxity, and
autism (Goizet et al. 2000; Praphanphoj et al. 2000;
Prasad et al. 2000). Although these symptoms are some-
what unspecific, it has been suggested that their asso-
ciation with delayed speech and mild mental retardation
should prompt clinicians to search for a 22q distal de-
letion. DNA studies of patients with 22q distal deletion
led to the identification of an SRO from below locus
D22S97 proximally to below ARSA (Nesslinger et al.
1994). The molecular definition of a terminal micro-
deletion led Wong and colleagues (1997) to narrow the
critical region to the distal 130 kb, from D22S163 to
the telomere. Because the distal 60 kb are probably rich
in subtelomeric repeats, the proximal remaining 70-kb
region is expected to contain one or more genes whose
haploinsufficiency accounts for the two main symptoms
of the 22q distal deletion (i.e., delayed speech and mild
mental retardation) (Wong et al. 1997). In this region
are localized the human homologue of ProSAP2, acrosin,
an SNRPA1 pseudogene, RABL2B (a member of the
RAS oncogene family), and a 60S ribososomal protein
L23A pseudogene (Dunham et al. 1999). Because RAB
mutations have been associated with X-linked mental
retardation (D’Adamo et al. 1998), the finding that
RABL2B was deleted in the patient with the critical 22q
deletion raised the possibility that its haploinsufficiency
was responsible for the patient’s abnormal phenotype
(Wong et al. 1999). However, the existence of RABL2A
(which is located at 2q13), given that it too is expressed
and is very close in sequence to RABL2B, makes
RABL2B unlikely to be dose sensitive (Wong et al. 1999).
We have studied a child who had all the symptoms
associated with the 22q distal deletion syndrome (se-
verely delayed expressive language, mild mental retar-
dation, hypotonia, dolichocephaly, epicanthic folds,
bulbous nose, and lax joints). The finding that he carries
a de novo balanced translocation resulting in the dis-
ruption of a gene localized in the 70-kb critical region
of chromosome 22q suggests that its haploinsufficiency
may be responsible for the 22q distal deletion syndrome
phenotype.
The product of the ProSAP2 gene localizes to the PSD,
a highly specialized submembranous network of pro-
teins at excitatory synapses of the CNS. The PSD in-
cludes a variety of adapter proteins that are involved in
localizing receptors, adhesion molecules, and molecules
of the intracellular signaling cascade within the synapse
(Ziff 1997). Boeckers and colleagues (1999a) isolated
cDNAs coding for ProSAP1, a PSD-95/disks-large/ZO-
1 (PDZ) domain protein that is highly enriched in the
PSD. Homology screening identified a related protein
(ProSAP2), which shares a highly conserved PDZ do-
main (80% identity), a proline-rich Src homology 3
(SH3) binding motif domain that mediates the inter-
action with cortactin, and a C-terminal sterile-alpha-
motif (SAM) domain. ProSAP2 contains five ankyrin
repeats and an SH3 domain. The ProSAP proteins can
bind the scaffold protein Homer and the SAPAP proteins
(Boeckers et al. 1999b), which, in turn, bind to PSD-95.
They can also form homomultimers, ultimately permit-
ting the formation of a three-dimensional network, link-
ing together the NMDA receptor complex on the PSD,
mGluRs in the membrane, and the IP3 receptor on in-
tracellular calcium-storage vesicles (Kennedy 2000).
The ProSAP proteins are coexpressed in many regions
of the rat brain, but show a distinct expression pattern
in the cerebellum. In fact, in most brain regions, in-
cluding the cerebral cortex and the hippocampus,
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ProSAP1 and ProSAP2 appear to be codistributed;
however, a complementary distribution is observed in
the cerebellum. ProSAP1 is primarily expressed in
Purkinje cells, whereas ProSAP2 transcripts are only
found in the granular cell layer of cerebellum. (Boeck-
ers et al. 1999b). Expression analysis in human tis-
sues confirms the results in rats and highlights the
exclusive expression of full-length Prosap2 in the ce-
rebral cortex and cerebellum.
The chromosome 12 gene disrupted by the translo-
cation codes for the FLJ10659 protein, which contains
a PH domain and shows similarity to the human APPL
protein (MIM 604299), a protein of unknown function
involved in binding to the tyrosine-kinase protein AKT2
(Mitsuuchi et al. 1999). Because the function of
FLJ10659 is also currently unknown, we cannot hy-
pothesize about the nature of any correlations between
FLJ10659 haploinsufficiency and the phenotype of our
patient.
The finding that our patient has symptoms that over-
lap with those of subjects who have distal 22q deletions
suggests that ProSAP2 haploinsufficiency is the cause of
this syndrome. The involvement of ProSAP2 protein in
the highly specialized cytoskeleton at the PSD is in close
agreement with this finding. Another syndrome that is
usually associated with haploinsufficiency of a cytoske-
letal protein is lissencephaly (Chong et al. 1997; Sapir
et al. 1999). The finding of ProSAP2 mutation in sub-
jects with the 22q distal deletion phenotype but no 22q
deletion would confirm that it is the causative gene.
However, this approach might be difficult because of
the rather unspecific phenotype of this syndrome.
Analysis of the sequences involved in the transloca-
tion did not uncover any known features that could be
directly responsible for the translocation. There is no
homology between the two regions. No repetitive se-
quences are present at or around the breakpoint on
chromosome 12 or 22. There is no unusually high
concentration of AT nucleotides or alternating pu-
rine/pyrimidine residues that could predispose to re-
arrangements. The only unique feature in this trans-
location is a 5-bp sequence, CTG(C/A)C, that is
present on chromosomes 12 and 22 at the breakpoint
(fig. 2). The presence of short common sequence mo-
tifs at the rearrangement sites of other constitutional
reciprocal translocations has been reported (Giacalone
and Franke 1992; Nothwang et al. 2000). Our findings
strengthen the hypothesis that the recombinational ma-
chinery recognizes the alignment of two DNAmolecules
with a small region of sequence homology.
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